Two Sigma Advisers’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,700
Closed -$298K 1680
2025
Q4
$298K Buy
+30,700
New +$261K ﹤0.01% 1983
2025
Q3
Sell
-11,100
Closed -$103K 2586
2025
Q2
$103K Sell
11,100
-8,500
-43% -$74.2K ﹤0.01% 2205
2025
Q1
$191K Sell
19,600
-150,800
-88% -$1.87M ﹤0.01% 2148
2024
Q4
$2.06M Sell
170,400
-18,000
-10% -$219K ﹤0.01% 1108
2024
Q3
$2.06M Sell
188,400
-21,300
-10% -$216K ﹤0.01% 1041
2024
Q2
$1.89M Sell
209,700
-12,900
-6% -$89.9K ﹤0.01% 1224
2024
Q1
$1.82M Buy
222,600
+19,900
+10% +$163K ﹤0.01% 1279
2023
Q4
$1.71M Sell
202,700
-18,700
-8% -$217K ﹤0.01% 1379
2023
Q3
$3.79M Sell
221,400
-57,600
-21% -$1.13M 0.01% 875
2023
Q2
$6.48M Buy
279,000
+52,900
+23% +$1.03M 0.02% 657
2023
Q1
$3.99M Buy
226,100
+114,200
+102% +$2.72M 0.01% 907
2022
Q4
$3.04M Sell
111,900
-10,800
-9% -$224K 0.01% 1008
2022
Q3
$2.12M Sell
122,700
-12,500
-9% -$238K 0.01% 1141
2022
Q2
$2.36M Sell
135,200
-59,700
-31% -$981K 0.01% 1126
2022
Q1
$3.31M Buy
194,900
+69,700
+56% +$1.32M 0.01% 996
2021
Q4
$3.39M Sell
125,200
-75,800
-38% -$2.27M 0.01% 938
2021
Q3
$5.96M Sell
201,000
-49,100
-20% -$1.59M 0.02% 706
2021
Q2
$9.61M Sell
250,100
-56,300
-18% -$1.93M 0.03% 583
2021
Q1
$9.35M Buy
306,400
+85,600
+39% +$3.21M 0.03% 596
2020
Q4
$8.42M Buy
220,800
+182,600
+478% +$7.61M 0.02% 628
2020
Q3
$879K Buy
+38,200
New +$871K ﹤0.01% 1557

Other funds holding REPL

Two Sigma Advisers's REPL Position: Q1 2026 in Review

Two Sigma Advisers sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 30,700 shares — an estimated $298K sold.

Two Sigma Advisers first reported a position in REPL in Q3 2020 and held it in 21 quarters. The position peaked at $9.61M in Q2 2021. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Two Sigma Advisers reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 30,700 Replimune Group shares in Q1 2026, an estimated $298K.
  • Two Sigma Advisers first reported a position in Replimune Group in Q3 2020 and held it in 21 quarters.
  • Two Sigma Advisers's Replimune Group position peaked at $9.61M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.